Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection

High mortality rates have been reported for patients co-infected with extensively drug-resistant tuberculosis (XDR-TB) and HIV, but treatment outcomes have not been reported. We report treatment outcomes for adult XDR TB patients in KwaZulu-Natal Province, South Africa. Initial data were obtained re...

Full description

Saved in:

Bibliographic Details
Published in:	Emerging infectious diseases Vol. 19; no. 3; pp. 416 - 424
Main Authors:	O’Donnell, Max R., Padayatchi, Nesri, Kvasnovsky, Charlotte, Werner, Lise, Master, Iqbal, Horsburgh, C. Robert
Format:	Journal Article
Language:	English
Published:	United States U.S. National Center for Infectious Diseases 01.03.2013 Centers for Disease Control and Prevention
Subjects:	Adolescent Adult Antitubercular Agents - therapeutic use bacteria Care and treatment Coinfection - drug therapy Coinfection - mortality Comorbidity Cycloserine - therapeutic use Drug Therapy, Combination Ethambutol - therapeutic use Ethionamide - therapeutic use extensively drug-resistant tuberculosis Extensively Drug-Resistant Tuberculosis - drug therapy Extensively Drug-Resistant Tuberculosis - mortality Female HIV HIV infection HIV Infections - drug therapy HIV Infections - mortality Humans Kaplan-Meier Estimate Male Middle Aged Patient outcomes Pyrazinamide - therapeutic use Retrospective Studies Treatment Outcome Tuberculosis tuberculosis and other mycobacteria Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - mortality viruses XDR TB Young Adult United States viruses HIV bacteria co-infection treatment outcomes XDR TB extensively drug-resistant tuberculosis tuberculosis and other mycobacteria South Africa
ISSN:	1080-6040, 1080-6059, 1080-6059
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!